Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 346 to 360 of 8916 results

  1. Antenatal care (NG201)

    This guideline covers the routine antenatal care that women and their babies should receive. It aims to ensure that pregnant women are offered regular check-ups, information and support.

    NICE guideline
    Published
    19 August 2021
    View recommendations

    Sections for NG201

  2. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)

    This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It aims to support rapid diagnosis and effective treatment for people who develop deep vein thrombosis (DVT) or pulmonary embolism (PE). It also covers testing for conditions that can make a DVT or PE more likely, such as thrombophilia (a blood clotting disorder) and cancer. It does not cover pregnant women.

    NICE guideline
    Last updated
    2 August 2023
    View recommendations

    Sections for NG158

  3. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215)

    This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants in primary and secondary care.

    NICE guideline
    Published
    20 April 2022
    View recommendations

    Sections for NG215

  4. Hyperparathyroidism (primary): diagnosis, assessment and initial management (NG132)

    This guideline covers diagnosing, assessing and managing primary hyperparathyroidism. It aims to improve recognition and treatment of this condition, reducing long-term complications and improving quality of life.

    NICE guideline
    Published
    23 May 2019
    View recommendations

    Sections for NG132

  5. Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancer [ID6168]

    In development Reference number: GID-TA11115 Expected publication date:  02 March 2026

    Technology appraisal guidance
    In development

  6. Metastases

    All NICE products on metastases. Includes any guidance, advice and quality standards.

    Topic page

  7. Acute coronary syndromes

    All NICE products on acute coronary syndromes. Includes any guidance, advice and quality standards.

    Topic page

  8. Stable angina

    All NICE products on stable angina. Includes any guidance, advice and quality standards.

    Topic page

  9. Structural heart defects

    All NICE products on structural heart defects. Includes any guidance and advice.

    Topic page

  10. Hypertension

    All NICE products on hypertension. Includes any guidance and quality standards.

    Topic page

  11. Vasculitis

    All NICE products on vasculitis. Includes any guidance.

    Topic page

  12. Adrenal dysfunction

    All NICE products on adrenal dysfunction. Includes any guidance.

    Topic page

  13. Eye conditions

    All NICE products on eye conditions. Includes any guidance, advice and quality standards.

    Topic page

  14. Pancreatitis

    All NICE products on pancreatitis. Includes any guidance and advice.

    Topic page

  15. Faecal incontinence

    All NICE products on faecal incontinence. Includes any guidance, advice and quality standards.

    Topic page